Cargando…
Considering gene therapy to protect from X‐linked deafness DFNX2 and associated neurodevelopmental disorders
Mutations and deletions in the gene or upstream of the gene encoding the POU3F4 transcription factor cause X‐linked progressive deafness DFNX2 and additional neurodevelopmental disorders in humans. Hearing loss can be purely sensorineural or mixed, that is, with both conductive and sensorineural com...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10529175/ https://www.ncbi.nlm.nih.gov/pubmed/37786584 http://dx.doi.org/10.1002/ibra.12068 |